- Home
- ARVN vs RSKD Comparison
ARVN vs RSKD Comparison
Compare ARVN & RSKD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARVN
- RSKD
- Stock Information
- Founded
- ARVN 2015
- RSKD 2012
- Country
- ARVN United States
- RSKD United States
- Employees
- ARVN N/A
- RSKD N/A
- Industry
- ARVN Biotechnology: Pharmaceutical Preparations
- RSKD EDP Services
- Sector
- ARVN Health Care
- RSKD Technology
- Exchange
- ARVN Nasdaq
- RSKD Nasdaq
- Market Cap
- ARVN 614.8M
- RSKD 579.2M
- IPO Year
- ARVN 2018
- RSKD 2021
- Fundamental
- Price
- ARVN $6.13
- RSKD $5.39
- Analyst Decision
- ARVN Buy
- RSKD Hold
- Analyst Count
- ARVN 19
- RSKD 8
- Target Price
- ARVN $21.14
- RSKD $5.66
- AVG Volume (30 Days)
- ARVN 3.3M
- RSKD 342.8K
- Earning Date
- ARVN 05-01-2025
- RSKD 05-14-2025
- Dividend Yield
- ARVN N/A
- RSKD N/A
- EPS Growth
- ARVN N/A
- RSKD N/A
- EPS
- ARVN N/A
- RSKD N/A
- Revenue
- ARVN $426,900,000.00
- RSKD $333,495,000.00
- Revenue This Year
- ARVN N/A
- RSKD $5.88
- Revenue Next Year
- ARVN N/A
- RSKD $10.69
- P/E Ratio
- ARVN N/A
- RSKD N/A
- Revenue Growth
- ARVN 498.74
- RSKD 10.05
- 52 Week Low
- ARVN $5.94
- RSKD $3.94
- 52 Week High
- ARVN $37.38
- RSKD $6.65
- Technical
- Relative Strength Index (RSI)
- ARVN 32.27
- RSKD 76.62
- Support Level
- ARVN $6.02
- RSKD $4.73
- Resistance Level
- ARVN $7.05
- RSKD $4.75
- Average True Range (ATR)
- ARVN 0.56
- RSKD 0.17
- MACD
- ARVN -0.12
- RSKD 0.07
- Stochastic Oscillator
- ARVN 2.87
- RSKD 98.81
About ARVN Arvinas Inc.
Arvinas Inc is a United States-based biopharmaceutical company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development and commercialization of therapies that degrade disease-causing proteins.. The company's proprietary Proteolysis-Targeting Chimera (PROTAC), work by inducing the cell's own ubiquitin-proteasome system to target, degrade and remove disease-causing proteins. The group's product candidates are bavdegalutamide, ARV-471 and ARV-766.
About RSKD Riskified Ltd.
Riskified Ltd has built a next-generation eCommerce risk management platform that allows online merchants to create trusted relationships with their consumers. It generates revenue by granting merchants access to its eCommerce risk management platform and reviewing and approving eCommerce transactions for legitimacy. Its merchants include some of the ecommerce brands including Wayfair, Lastminute.com, SHEIN, and Macy's. Its merchants operate in a variety of verticals, including Payments, Money Transfer & Crypto, Tickets & Travel, Electronics, Home, Fashion & Luxury Goods, General Retail and Food. The company derived maximum revenue from Israel.